|

Interview With Daniel Carcillo

ByPsychedelic Spotlight

Similar Posts

  • MindMed Stock Catalysts for 2021: NASDAQ, Clinical Trial Results and More (MMED / MMEDF)

    Listen, Videos

    In today’s episode, we discuss :MindMed Stock Catalysts for 2021: NASDAQ, Clinical Trial Results and More (MMED / MMEDF).

    2020 was a wild year for MindMed, with the company IPOing in March, at just over 20c/ share, all prices in American currency. Then, the MindMed stock price shot up to a high of $4.37 in December, only to fall about 30% and consolidate around $3 a share in the new year.

    But what will be the main catalysts for MindMed and its stock going forward in 2021? Put another way, what are the events and dates that shareholders and potential investors should circle on their calendars?

    In this episode, we are going to talk about several catalysts to look out for
    1. MindMed’s Nasdaq uplisting
    – When to expect MindMed to join the Nasdaq?
    – Is MindMed’s uplisting a sure thing?
    -What will happen to MindMed stock if/when the company gets uplisted?

    2. Clinical trials wrapping up, and data being released by MindMed
    – Important dates MindMed investors should circle in their calendars
    3. MindMed’s quarter end financial reporting
    4. MindMed conference calls

    Unknown Catalysts for Mindmed:
    1. Clinical trials expansions
    2. Financial agreements

    ** Also, on the 20th of January, Kevin O’Leary and Jr Rahn went live discussing MindMed. For those who haven’t seen it, Jr mentioned a few extra catalysts we should be looking forward to which we will discuss in our next episode.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    https://www.prnewswire.com/news-releases/atai-life-sciences-announces-closing-of-125-million-series-c-financing-round-301178915.html

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed #MMED #MMEDF

  • Dr. Matthew Johnson discusses Psychedelics, the Hard Problem of Consciousness and UFOs

    Listen, Videos

    During our time in Wonderland Miami, we had the pleasure to meet and interview Dr. Matthew Johnson of Johns Hopkins University. In this Psychedelic Spotlight Interview, we discuss a wide range of topics surrounding psychedelics and their effectiveness as treatments for ailments like tobacco addiction and PTSD. Of course, our conversation took as spin as we also touched on topics such as UFOs, DMT experiences and the CIA!

    Timestamps:

    0:00 – Intro
    1:10 – Dr. Johnson’s latest updates on treating smoking cessation with psilocybin
    6:55 – MAPS’ study using MDMA to treat PTSD
    7:20 – DMT’S mystical experiences of perceiving aliens, machine elves and autonomous beings
    13:08 – CIA research on psychedelics for telepathy and remote viewing
    15:01 – What is consciousness?
    19:02 – The intriguing evidence of UFOs?
    21:40 – Where do we see psychedelics going in the next 5 years?

    Make sure to like, share and subscribe if you enjoyed this episode!

    #Psychedelics #MatthewJohnson #UFO